Loading companies…
Loading companies…
France · Biotech
Develops an off-the-shelf in vivo immunotherapy platform for solid tumors
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | €11M | Angelor — Role not disclosedBIO JAG — Role not disclosedBpifrance — Role not disclosedCrédit Agricole — Role not disclosedKorea Omega Investment Corp — Role not disclosedNoshaq — Role not disclosedOrsa — Role not disclosedSambrinvest — Role not disclosedUI Investissement — Role not disclosed |